Convatec Group PLC (LON:CTEC) Stock Has Consensus Target Price of GBX 305.44 According to Brokerages

Convatec Group PLC (LON:CTEC) has received a consensus recommendation of “Moderate Buy” from the nine ratings firms that are presently covering the stock, Marketbeat reports. One analyst has rated the stock with a hold rating and eight have issued a buy rating on the company. The average 1 year target price among brokers that have updated their coverage on the stock in the last year is GBX 305.44.

Several brokerages have issued reports on CTEC. Peel Hunt reaffirmed an “add” rating and issued a GBX 270 price target on shares of Convatec Group in a report on Tuesday, August 4th. Berenberg Bank decreased their price target on Convatec Group from GBX 340 to GBX 335 and set a “buy” rating on the stock in a research note on Friday, September 11th. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and set a GBX 315 price target on shares of Convatec Group in a research note on Wednesday, August 5th. Royal Bank Of Canada restated an “outperform” rating and issued a GBX 315 price objective on shares of Convatec Group in a report on Monday, August 3rd. Finally, Jefferies Financial Group reaffirmed a “buy” rating and set a GBX 300 price target on shares of Convatec Group in a research report on Wednesday, August 5th.

Insiders Place Their Bets

In related news, insider Tobias Hestler purchased 50,000 shares of Convatec Group stock in a transaction dated Thursday, August 6th. The shares were acquired at an average price of GBX 226 per share, with a total value of £113,000. Also, insider Jens Viebke bought 24,400 shares of the firm’s stock in a transaction dated Tuesday, October 13th. The stock was purchased at an average price of GBX 230 per share, with a total value of £56,120. 0.98% of the stock is currently owned by company insiders.

Convatec Group Price Performance

Shares of LON:CTEC opened at GBX 241.80 on Friday. The firm has a market capitalization of £4.64 billion, a price-to-earnings ratio of 39.00, a price-to-earnings-growth ratio of 0.93 and a beta of 0.77. The company has a debt-to-equity ratio of 121.83, a current ratio of 1.93 and a quick ratio of 0.96. The business’s 50 day simple moving average is GBX 224.88 and its 200-day simple moving average is GBX 223.12. Convatec Group has a 12 month low of GBX 193 and a 12 month high of GBX 259.30.

Convatec Group Company Profile

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer.